期刊文献+

消化系统肿瘤FDG PET/CT显像标准摄取值与分子生物学的相关性 被引量:1

The association of FDG-PET/CT SUV with molecular biology in digestive canal cancer
原文传递
导出
摘要 目的探讨消化系统肿瘤PET/CT显像FDG标准摄取值(SUV)与其分子生物学行为的相关性。方法回顾性分析资料完整的24例消化系统肿瘤患者PET/CT、手术和病理资料,分析患者PET/CT显像FDG摄取指数SUV值与癌肿浸润深度、转移状况之间的相关性以及与肿瘤增殖因子Ki-67、癌基因p53、癌基因C-erbB-2表达的相关性。结果 24例消化系统肿瘤患者SUV值最低为2.5,最高为12,平均值6.34±2.54,按SUV值高低将患者病变均分为低代谢和高代谢两组,低代谢组SUV均值4.39±1.31,高代谢组SUV均值8.48±1.38,两组间SUV值均数差异有统计学意义(t=2.418,P<0.05),两组间病变浸润深度差异无统计学意义(χ2=0,P>0.05),两组间病变邻近淋巴结转移发生率无统计学意义(χ2=0.686,P>0.05)。24例患者病变Ki-67值最低为20%,最高为65%,平均值(41±11)%。SUV值与Ki-67值相关性无统计学意义(r=-0.22,P>0.05)。低代谢组和高代谢组Ki-67值分别为(43±13)%和(38±9)%,组间差异无统计学意义(t=0.225,P>0.05)。低代谢组和高代谢组p53阳性表达例数差异无统计学意义(χ2=0.711,P>0.05)。低代谢组和高代谢组C-erbB-2阳性表达例数差异无统计学意义(χ2=0.686,P>0.05)。结论消化系统肿瘤PET/CT显像FDG摄取指数SUV值变异较大,与癌肿浸润深度和邻近淋巴结有无转移之间没有相关性,与肿瘤增殖因子Ki-67、癌基因p53及C-erbB-2表达程度无显著相关性。 Objective To investigate the association of FDG uptake index of digestive canal cancer PET image with molecular biological behaviour.Methods Twenty-four patients with digestive canal cancer with complete PET/CT,surgical operation and pathology data were enrolled.Retrospectivly analyzed the correlation between FDG uptake index(SUV value) and cancer infiltration,and lymph node metastasis and Ki-67,p53,C-erbB-2 expression.Results The FDG uptake index SUV value of 24 subjects,the lowest was 2.5,the highest was 12,the average was 6.34 ± 2.54,were divided equally into hypometabolism group and hypermetabolism group,hypometabolism group average SUV was 4.39 ± 1.31,hypermetabolism group average SUV was 8.48 ± 1.38,the discrepance of SUV average value between two groups had statistical significance(t =2.418,P 〈0.05),the discrepance of cancer infiltrating depth had no statistical significance(χ2 =0,P 〉 0.05),the discrepance of incidence of lymphaden metastasis had no statistical significance(χ2 = 0.686,P 〉 0.05) .The Ki-67 value of 24 subjects,the lowest was 20%,the highest was 65%,the average was(41 ± 11) % .The associativity of SUV value and Ki-67 value had no statistical significance(r =-0.22,P 〉 0.05) .The Ki-67 value of hypometabolism and hypermetabolism were(43 ± 13) % and(38 ± 9) % respectively,the discrepance of two groups had no statistical significance(t = 0.225,P 〉 0.05 ) .The discrepance of p53 positive cases of hypometabolism and hypermetabolism had no statistical significance(χ2 =0.711,P 〉0.05) .The discrepance of C-erbB-2 positive cases of hypometabolism and hypermetabolismhad no statistical significance(χ2 = 0.686,P 〉 0.05) .Conclusions The SUV of digestive canal cancer PET image 18F-FDG standard uptake value had comparatively large variation,had no significant associativity with cancer infiltrating depth and neighbourhood lymphaden metastases,had no significant associativity with the expression of tumor multiplication factor Ki-67,oncogene p53 and C-erbB-2.
机构地区 解放军第
出处 《中华临床医师杂志(电子版)》 CAS 2010年第8期40-44,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 消化系统肿瘤 正电子发射断层显像术 病理学 分子生物学 Digestive system neoplasms Positron-emission tomography Pathology Molecular biology
  • 相关文献

参考文献24

  • 1欧阳林,刘士远,肖湘生.肠周脂肪CT征象在诊断肠疾病中的临床价值[J].中国医学影像技术,2009,25(3):462-464. 被引量:14
  • 2Al-Sarraf N,Gately K,Lucey J,et al.Clinical implication and prognostic significance of standardised uptake value of primary non -small cell lung cancer on positron emission tomography:analysis of 176 cases.Eur J Cardiothorac Surg,2008,34(4):892-897.
  • 3Cascini GL,Avallone A,Delrio P,et al.18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.J Nucl Med,2006,47(8):1241-1248.
  • 4Geus-Oei LF,Oyen WJ.Predictive and prognostic value of FDG-PET.Cancer Imaging,2008,8:70-80.
  • 5Eschmann SM,Friedel G,Paulsen F,et al.18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.Eur J Nucl Med Mol Imaging,2007,34(4):463-471.
  • 6De Leyn P,Stroobants S,De Wever W,et al.Prospective comparative study of integrated positron emission tomography -computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage ⅢA-N2 Non-small-cell lung cancer:a Leuven Lung Cancer Group Study.J Clin Oncol,2006,24(21):3333-3339.
  • 7Buchmann I,Ganten TM,Haberkorn U.[18F] -FDG-PET in the diagnostics of gastrointestinal tumors.Z Gastroenterol,2008,46(4):367-375.
  • 8Saga T,Nakamoto Y,Higashi T,et al.Positron emission tomography for the diagnosis and management of patients with gastrointestinal malignancies.Gastrointest Endosc Clin N Am,2008,18(3):479-493,ix.
  • 9Shin SS,Jeong YY,Min JJ,Preoperative staging of colorectal cancer:CT vs.integrated FDG PET/CT.Abdom Imaging,2008,33(3):270-277.
  • 10de Geus-Oei LF,Ruers TJ,Punt CJ,et al.FDG-PET in colorectal cancer.Cancer Imaging,2006,6:S71-81.

二级参考文献27

共引文献22

同被引文献20

  • 1胡伟汉,张国义,刘立志,吴湖炳,李立,高远红,潘燚,王全师.PET-CT与MRI诊断鼻咽癌淋巴结转移的对比研究[J].癌症,2005,24(7):855-860. 被引量:33
  • 2Chan AT.Nasopharyngeal carcinoma.Ann Oncol,2010,21Suppl7:vii308-312.
  • 3Tao Q,Chan AT.Nasopharyngeal carcinoma:molecular pathogenesis and therapeutic developments.Expert Rev Mol Med,2007,9:1-24.
  • 4Ng WT,Lee AW,Kan WK,et al.N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma:pattern of nodal involvement by radiological levels.Radiother Oncol,2007,82:70-75.
  • 5Mao YP,Liang SB,Liu LZ,et al.The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging.Clin Cancer Res,2008,14:7497-7503.
  • 6Kao CH,Hsieh JF,Tsai SC,et al.Comparison of18-fluorodeoxyglucose posit ron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.Ann Otol Rhinol Laryngol,2000,109:1130-1134.
  • 7Yen TC,Chang YC,Chan SC,et al.Are dual-phase18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?Eur J Nucl Med Mol Imaging,2005,32:541-548.
  • 8Chang JT,Chan SC,Yen TC,et al.Nasopharyngeal carcinoma staging by(18)F-fluorodeoxyglucose positron emission tomography.Int J Radiat Oncol Biol Phys,2005,62:501-507.
  • 9Cooper J,Fleming ID,Henson DE,et al.American Joint Committee on Cancer manual for staging of cancer.6th ed.Philadelphia:JB Lippincott,2002.
  • 10Ng SH,Chang JT,Chan SC,et al.Nodal metastases of nasopharyngeal carcinoma:patterns of disease on MR and FDG PET.Eur J Nucl Med Mol Imaging,2004,31:1073-1080.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部